Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03624374 · ClinicalTrials.gov registry record

Natural History Study of Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL)

A clinical trial of Genetic Disease and White Matter Disease, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT03624374 is a study of Genetic Disease and White Matter Disease that is actively recruiting participants, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 100 participants, below the 2,558-participant average among 30 other Genetic Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03624374, a study of Genetic Disease and White Matter Disease, is actively recruiting participants, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

In this study, we will conduct retrospective chart and imaging reviews and prospective longitudinal virtual assessments of individuals with LBSL.

Study Locations (1)

Maryland

  • Hugo Moser Center for Leukodystrophies - Baltimore

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-04-01
Est. Completion 2029-05

What the Registry Record Tells You About NCT03624374

The ClinicalTrials.gov registry entry for NCT03624374 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,558-participant average among 30 other Genetic Disease trials with a reported enrollment target (96% lower). The listed sponsor is Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Genetic Disease appearing as the primary indexed condition, and to 0 interventions.

NCT03624374 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03624374 about?

NCT03624374 is a clinical study titled "Natural History Study of Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL)". In this study, we will conduct retrospective chart and imaging reviews and prospective longitudinal virtual assessments of individuals with LBSL.

What is the current status of trial NCT03624374?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2018-04-01. Estimated completion is 2029-05.

What conditions does trial NCT03624374 study?

This clinical trial studies the following conditions: Genetic Disease, White Matter Disease, Leukoencephalopathies, LBSL, Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation.

Who is sponsoring clinical trial NCT03624374?

This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03624374 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Genetic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.